NANOCBD-S
Dead / Abandoned — Abandoned — failure to respond (as of 11 Aug 2023)
What this means for you
This application is over — abandoned 25 Jul 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79339591
- Mark type
- Stylized text
- Filed
- 28 Feb 2022
- Abandoned
- 25 Jul 2023
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations and substances including pharmaceutical and medicinal preparations incorporating sub-micron particles; dietetic substances adapted for medical use; vitamins and vitamin supplements; dietary and nutritional products for medical purposes; dietary and nutritional supplements; minerals and mineral supplements; nutritional supplements; plant extracts for medical use; medicinal herbs for pharmaceutical and medicinal preparations and substances; herbal preparations for medicinal purposes; medicinal herbs for pharmaceutical and medicinal preparations and substances incorporating sub-micron particles; herbal preparations for medicinal purposes incorporating sub-micron particles
Owner
Prosecution history
- 31 Aug 2024 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 12 Aug 2024 — FINAL DISPOSITION NOTICE SENT TO IB
- 12 Aug 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 11 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 11 Oct 2023 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 11 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 11 Aug 2023 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 11 Aug 2023 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 14 Feb 2023 — REFUSAL PROCESSED BY IB
- 24 Jan 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 24 Jan 2023 — REFUSAL PROCESSED BY MPU
- 20 Nov 2022 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 19 Nov 2022 — NON-FINAL ACTION WRITTEN
- 07 Nov 2022 — ASSIGNED TO EXAMINER